EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Whole‐genome paternal uniparental disomy identified through prenatal single‐nucleotide polymorphism‐based cell‐free DNA screening

P Benn iD, K Hashimoto, V Souter, R Dhamankar, W Xu, D Kijacic

Ultrasound in Obstetrics & Gynecology · 2026

DOI: 10.1002/uog.70144 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Ultrasound in Obstetrics & Gynecology, 2026. Verfasst von P Benn und 5 weiteren Autor:innen. Beteiligte Einrichtung: University of Connecticut Health Center, Farmington, CT, USA. Hauptthemen laut MEDLINE: Uniparental Disomy, Polymorphism, Single Nucleotide, Cell-Free Nucleic Acids, Noninvasive Prenatal Testing. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Natera.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Prenatal single‐nucleotide polymorphism (SNP)‐based cell‐free DNA (cfDNA) screening can identify genome‐wide paternal uniparental disomy (GW‐UPDpat), including cases with complete hydatidiform mole with a coexisting fetus (CHMCF), those with placental mesenchymal dysplasia (PMD) and those with a mosaic/chimeric GW‐UPDpat syndrome. Our objective was to review laboratory data and pregnancy outcome for SNP‐based cfDNA screening tests with results compatible with GW‐UPDpat and a normal cell line.

Methods

This was a retrospective study of all cfDNA screening results from a single commercial laboratory between June 2014 and November 2023 that were reported as twins or triploidy, with apparent GW‐UPDpat. Two‐dimensional representations of the relative ratios of SNP alleles (SNP plots) were used to identify and quantify the proportion of cfDNA from the mole (‘molar fraction’) and that from the coexisting non‐molar pregnancy (‘fetal fraction’). Test referral and follow‐up information, including ultrasound findings, laboratory testing and pregnancy outcome, were reviewed.

Results

Of 5 699 009 tests reviewed, 89 were reported as twins or triploidy, with apparent GW‐UPDpat. Retrospective review of SNP plots excluded 12 cases that were reinterpreted as triploidy with an extra set of paternal chromosomes. Of the remaining 77 cases, 24 had follow‐up pregnancy information available, and of these, 21 (87.5%) had ultrasound and/or pathology findings that were consistent with CHMCF. The fetal cfDNA fraction was often very low (≤ 2% in 28 cases). The molar cfDNA fraction was in the range of 10–58%. Fetal sex was male in 35 cases, female in 40 cases and uncertain in two cases. No case showed clear evidence of a Y‐chromosome in the GW‐UPDpat line. All 77 cases had isodisomy; none showed clear evidence of regions of heterodisomy.

Conclusions

SNP‐based cfDNA screening can help to identify CHMCF and distinguish between CHMCF and triploidy. For CHMCF, early detection is important for evaluating the risk of adverse outcome and gestational trophoblastic neoplasia. Some of our test‐positive cases could have included unrecognized PMD or mosaic/chimeric GW‐UPDpat syndrome. These preliminary observations do not allow assessment of the sensitivity or positive predictive value of this test. © 2025 Natera, Inc. Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd on behalf of International Society of Ultrasound in Obstetrics and Gynecology.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Uniparental DisomyPolymorphism, Single NucleotideCell-Free Nucleic AcidsNoninvasive Prenatal TestingPrenatal DiagnosisHumansFemalePregnancyRetrospective StudiesAdultHydatidiform MolePregnancy OutcomeMale

Stichwörter der Autor:innen

SNP plotcfDNA screeningcomplete hydatidiform mole with coexisting fetusgenomic imprinting disordernon‐invasive prenatal testingprenatal detectionuniparental disomy

Substanzen

Cell-Free Nucleic Acids

Autor:innen und Institutionen

  • University of Connecticut Health Center, Farmington, CT, USA.
  • Natera, Inc., Austin, TX, USA.

ORCID-Profile: P Benn

Förderung

  • Natera

Zitieren

APA

Benn, P., Hashimoto, K., Souter, V., Dhamankar, R., Xu, W., & Kijacic, D. (2026). Whole‐genome paternal uniparental disomy identified through prenatal single‐nucleotide polymorphism‐based cell‐free DNA screening. Ultrasound in Obstetrics & Gynecology. https://doi.org/10.1002/uog.70144

Vancouver

Benn P, Hashimoto K, Souter V, Dhamankar R, Xu W, Kijacic D. Whole‐genome paternal uniparental disomy identified through prenatal single‐nucleotide polymorphism‐based cell‐free DNA screening. Ultrasound in Obstetrics & Gynecology. 2026. doi:10.1002/uog.70144

BibTeX
@article{Benn2026,
  author = {Benn, P and Hashimoto, K and Souter, V and Dhamankar, R and Xu, W and Kijacic, D},
  title = {Whole‐genome paternal uniparental disomy identified through prenatal single‐nucleotide polymorphism‐based cell‐free DNA screening},
  journal = {Ultrasound in Obstetrics & Gynecology},
  year = {2026},
  doi = {10.1002/uog.70144}
}
Kostenlos starten →